{"id":"https://openalex.org/W1965062797","doi":"https://doi.org/10.1080/1042819031000077124","title":"Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression","display_name":"Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W1965062797","doi":"https://doi.org/10.1080/1042819031000077124","mag":"1965062797","pmid":"https://pubmed.ncbi.nlm.nih.gov/12854905"},"language":"en","primary_location":{"id":"doi:10.1080/1042819031000077124","doi":"https://doi.org/10.1080/1042819031000077124","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1042819031000077124","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038660651","display_name":"Eunice S. Wang","orcid":"https://orcid.org/0000-0002-8644-0968","observed_orcids":["https://orcid.org/0000-0002-8644-0968"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eunice S. Wang","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021-6306, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021-6306, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen O'Connor","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085810259","display_name":"Yuhong She","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuhong She","raw_affiliation_strings":["Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061964017","display_name":"Andrew David Zelenetz","orcid":"https://orcid.org/0000-0003-1403-6883","observed_orcids":["https://orcid.org/0000-0003-1403-6883"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew D. Zelenetz","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113546804","display_name":"F. M. Sirotnak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F.M. Sirotnak","raw_affiliation_strings":["Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110863459","display_name":"Malcolm A.S. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malcolm A.S. Moore","raw_affiliation_strings":["Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":1.2444,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.77196394,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"44","issue":"6","first_page":"1027","last_page":"1035"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.5439000129699707,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.09030000120401382,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.044599998742341995,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7509999871253967},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9929999709129333},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/folate-metabolism","display_name":"folate metabolism","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cancer-cell-sensitivity","display_name":"tumor cell sensitivity","score":0.3319999873638153},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.7269999980926514},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9340000152587891},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6669999957084656},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6079999804496765},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6027975082397461},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5633985996246338},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5596973896026611},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5028011798858643},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.4927552044391632},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.44196346402168274},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36228325963020325},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36227601766586304},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3507809638977051},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32210272550582886},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.31866422295570374},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.212782621383667},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000630","descriptor_name":"Aminopterin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000630","descriptor_name":"Aminopterin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000630","descriptor_name":"Aminopterin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/1042819031000077124","doi":"https://doi.org/10.1080/1042819031000077124","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1042819031000077124","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:12854905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12854905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4062555065","display_name":null,"funder_award_id":"CA-0172","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8187160706","display_name":null,"funder_award_id":"CA-09207-24","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000898892","display_name":"Investigational Cancer Therapeutics Training Program (ICTTP)","funder_award_id":"T32CA009207","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W19840521","https://openalex.org/W134244161","https://openalex.org/W1537057577","https://openalex.org/W1551102474","https://openalex.org/W1779237600","https://openalex.org/W1889566095","https://openalex.org/W1914608195","https://openalex.org/W1979012566","https://openalex.org/W1985025279","https://openalex.org/W1991449455","https://openalex.org/W1995246889","https://openalex.org/W1999147615","https://openalex.org/W2006945828","https://openalex.org/W2012459434","https://openalex.org/W2037904434","https://openalex.org/W2039071189","https://openalex.org/W2043804660","https://openalex.org/W2054268096","https://openalex.org/W2064208261","https://openalex.org/W2083424038","https://openalex.org/W2096374402","https://openalex.org/W2102682710","https://openalex.org/W2120553565","https://openalex.org/W2126974953","https://openalex.org/W2129321368","https://openalex.org/W2136687348","https://openalex.org/W2140359066","https://openalex.org/W2142643115","https://openalex.org/W2146272190","https://openalex.org/W2147246240","https://openalex.org/W2149195756","https://openalex.org/W2150454353","https://openalex.org/W2161501094","https://openalex.org/W2168934491","https://openalex.org/W2278728288","https://openalex.org/W2314709769","https://openalex.org/W2334437685","https://openalex.org/W2341437337","https://openalex.org/W2400544314","https://openalex.org/W2416019199","https://openalex.org/W2421295198","https://openalex.org/W2472144914","https://openalex.org/W2953075056"],"related_works":["https://openalex.org/W2341942336","https://openalex.org/W2265246850","https://openalex.org/W2054268096","https://openalex.org/W1972821708","https://openalex.org/W2004463923","https://openalex.org/W2328359736","https://openalex.org/W2914487618","https://openalex.org/W2164379394","https://openalex.org/W2311781984","https://openalex.org/W3083952306"],"abstract_inverted_index":{"PDX":[0,18,48,78,134,153,185,215,252],"(10-propargyl-10-deazaaminopterin)":[1],"is":[2,33],"a":[3,241],"novel":[4],"anti-folate":[5],"with":[6,121,152,159,217,222],"improved":[7],"membrane":[8],"transport":[9],"and":[10,27,49,68,181,189,263,267],"polyglutamylation":[11],"in":[12,25,35,75,86,102,113,207,225],"tumor":[13,171,234],"cells.":[14],"In":[15,167],"prior":[16],"studies,":[17],"exhibited":[19],"enhanced":[20],"efficacy":[21,46],"over":[22],"methotrexate":[23],"(MTX)":[24],"lung":[26],"breast":[28],"carcinoma":[29],"xenografts.":[30],"Because":[31],"MTX":[32,50,85,130,160,197,262],"active":[34],"the":[36,45,101,125,202,251],"treatment":[37,161],"of":[38,47,105,129,148,178,204,233,243],"aggressive":[39],"non-Hodgkin's":[40],"lymphoma":[41,53],"(NHL),":[42],"we":[43],"compared":[44,100],"against":[51,107,258],"five":[52],"cell":[54,88],"lines:":[55],"RL":[56],"(transformed":[57],"follicular":[58],"lymphoma),":[59],"HT,":[60],"SKI-DLBCL-1":[61],"(diffuse":[62],"large":[63],"B":[64],"cell),":[65],"Raji":[66],"(Burkitt's),":[67],"Hs445":[69],"(Hodgkin's":[70],"disease).":[71],"After":[72],"5-day":[73],"continuous":[74],"vitro":[76],"exposure,":[77],"demonstrated":[79,210],">":[80],"10-fold":[81],"greater":[82,255],"cytotoxicity":[83],"than":[84,261],"all":[87],"lines":[89],"(IC50PDX":[90],"=":[91,95],"3-5":[92],"nM,":[93],"IC50MTX":[94],"30-50":[96],"nM).":[97],"We":[98],"then":[99],"vivo":[103],"effects":[104],"anti-folates":[106],"three":[108],"established":[109],"human":[110,259],"NHL":[111,260],"xenografts":[112],"NOD/SCID":[114],"mice.":[115],"Tumor":[116],"bearing":[117,172],"animals":[118],"were":[119],"treated":[120,151,158],"saline":[122],"(control)":[123],"or":[124,133,227],"maximum":[126],"tolerated":[127],"doses":[128],"(40":[131],"mg/kg)":[132,136],"(60":[135],"via":[137],"an":[138],"intraperitoneal":[139],"route":[140],"twice":[141],"weekly":[142],"for":[143,201],"2":[144],"weeks.":[145],"Almost":[146],"90%":[147],"HT":[149],"lymphomas":[150],"completely":[154],"regressed,":[155],"whereas,":[156],"those":[157],"had":[162,174],"only":[163,190],"modest":[164],"growth":[165,192],"delays.":[166],"two":[168],"other":[169],"xenografts,":[170],"mice":[173],"complete":[175],"regression":[176],"rates":[177],"56%":[179],"(RL)":[180],"30%":[182],"(SKI-DLBCL-1)":[183],"after":[184,196],"therapy.":[186,198],"No":[187],"regressions":[188],"minor":[191],"inhibition":[193],"was":[194],"noted":[195],"RT-PCR":[199],"analysis":[200],"expression":[203,221,237],"genes":[205],"involved":[206],"folate":[208],"metabolism":[209],"that":[211,231,250],"increased":[212],"sensitivity":[213],"to":[214,245],"correlated":[216],"higher":[218],"RFC-1":[219,235],"gene":[220,236],"no":[223],"difference":[224],"FPGS":[226],"FPGH":[228],"levels,":[229],"suggesting":[230],"measurement":[232],"level":[238],"may":[239],"be":[240],"predictor":[242],"response":[244],"PDX.":[246],"These":[247],"results":[248],"demonstrate":[249],"has":[253],"markedly":[254],"potential":[256],"activity":[257],"warrants":[264],"further":[265],"preclinical":[266],"clinical":[268],"evaluation.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}